Intellia (NTLA) | Stock Overview & Key Data
Intellia Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $202.73 on June 28, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Intellia
NTLA
|
1.59B Small-cap | 11.67% | 13.10% | -8.87% | 67.10% | 52.77% | 104.80% | -65.65% | -80.52% | -51.15% | -36.33% | -36.33% |
|
Vertex
VRTX
|
109.45B Large-cap | -2.03% | -0.35% | -9.68% | -7.51% | -5.26% | 1.24% | 34.08% | 113.19% | 376.31% | 717.28% | 1,190.86% |
|
Regeneron
REGN
|
80.98B Large-cap | -1.40% | -12.73% | -19.27% | -14.47% | -20.27% | 25.39% | -16.92% | 20.10% | 53.41% | 959.24% | 4,557.42% |
|
Adaptive
ADPT
|
2.13B Mid-cap | 15.53% | 10.28% | -0.56% | -6.65% | 0.50% | 59.14% | 103.08% | -57.83% | -68.63% | -68.63% | -68.63% |
|
Zymeworks
ZYME
|
1.96B Small-cap | -1.77% | -9.07% | -0.41% | -7.13% | -8.53% | 119.86% | 189.85% | -20.78% | 93.31% | 93.31% | 93.31% |
|
Agios
AGIO
|
1.48B Small-cap | -3.28% | 0.44% | -2.81% | 0.69% | 1.84% | -8.38% | 12.86% | -48.96% | -48.24% | 3.05% | 3.05% |
Ownership & Short Interest
Calculate Your Intellia Investment Returns
Long-Term Investment Performance Analysis
Intellia stock price in May 2016 was $28.80, A $1,000.00 lump sum investment in Intellia made 9 years ago would be worth approximately $319.44 today, representing a negative return of -68.06%. This translates to an annualized return (CAGR) of -11.84%.
9 Years Investment Scenario (May 2016 - Jun 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NTLA's 52-week high and low?
- In the last 52 weeks, Intellia reached a high of $28.18 (on July 17, 2024) and a low of $5.90 (on April 7, 2025).
- What is the market cap and P/E ratio for NTLA?
- Curious about Intellia's size and valuation? Its market capitalization stands at 1.59B. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.54, and the forward P/E (looking ahead) is -4.62.
- Does NTLA pay dividends? If so, what's the yield?
- As for dividends, Intellia isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Intellia's main competitors or similar companies to consider before investing?
When looking at Intellia, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology 1.24% 34.08% Regeneron
REGN80.98B Healthcare Biotechnology 25.39% -16.92% Adaptive
ADPT2.13B Healthcare Biotechnology 59.14% 103.08% Zymeworks
ZYME1.96B Healthcare Biotechnology 119.86% 189.85% Agios
AGIO1.48B Healthcare Biotechnology -8.38% 12.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Intellia Therapeutics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Intellia's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -53.48%, the Debt to Equity ratio from the most recent quarter is 13.90, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NTLA?
- Looking at Intellia's growth, its revenue over the trailing twelve months (TTM) was $68M. Compared to the same quarter last year (YoY), quarterly revenue grew by 78.80%, and quarterly earnings saw a YoY growth of 78.79%.
- How much of NTLA stock is held by insiders and institutions?
- Wondering who owns Intellia stock? Company insiders (like executives and directors) hold about 4.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 85.43%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.